Tiger Pharmaceuticals: Shareholder Cao Xiaochun, who holds more than 5% of the shares, plans to reduce his holdings by no more than 3 million shares.

Tiger Pharmaceuticals announced that the company's shareholder, director, and general manager Cao Xiaochun, who holds more than 5% of the shares, plans to reduce his holdings of the company's shares by no more than 3 million shares within 3 months after 15 trading days from the disclosure of the announcement, through centralized bidding and/or block trading methods. This represents 0.3508% of the total share capital of the company excluding repurchased shares, and 0.4098% of the total A-share capital of the company. The reason for the reduction is to repay debts and interest, and reduce the risk of pledged financing.